Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000016

President and CEO acquired 226,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Brunn Carsten · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-03 Grant or award : show line 1 in the form +226,300 531,555 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-03 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +1,056,100 1,056,100 D
Loading xslF345X03/wf-form4_164141830853581.xml…